Medochemie is a member of the Critical Medicines Alliance and has an extensive portfolio of the EU shortlisted critical medicines, as these were defined by the Commission, which are produced at our European authorised facilities. A lot of these critical medicines produced by Medochemie also play a key role in the fight against microbial resistance as they are old molecules facing less resistance by bacteria.
